BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14581165)

  • 1. Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer.
    Igarashi A; Konno H; Tanaka T; Nakamura S; Sadzuka Y; Hirano T; Fujise Y
    Toxicol Lett; 2003 Nov; 145(2):133-41. PubMed ID: 14581165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models.
    Shi R; Li C; Jiang Z; Li W; Wang A; Wei J
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28085075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photofrin
    Baran TM
    Lasers Surg Med; 2018 Jul; 50(5):476-482. PubMed ID: 29214668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model.
    Cheung R; Solonenko M; Busch TM; Del Piero F; Putt ME; Hahn SM; Yodh AG
    J Biomed Opt; 2003 Apr; 8(2):248-52. PubMed ID: 12683850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells.
    Hajri A; Wack S; Meyer C; Smith MK; Leberquier C; Kedinger M; Aprahamian M
    Photochem Photobiol; 2002 Feb; 75(2):140-8. PubMed ID: 11883602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phototoxicity of photofrin was enhanced by PEGylated liposome in vitro.
    Sadzuka Y; Tokutomi K; Iwasaki F; Sugiyama I; Hirano T; Konno H; Oku N; Sonobe T
    Cancer Lett; 2006 Sep; 241(1):42-8. PubMed ID: 16303246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor delivery of Photofrin® by PLL-g-PEG for photodynamic therapy.
    Kano A; Taniwaki Y; Nakamura I; Shimada N; Moriyama K; Maruyama A
    J Control Release; 2013 May; 167(3):315-21. PubMed ID: 23454112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antitumor activity of a novel porphyrin-based photosensitizer for photodynamic therapy.
    Chen JJ; Hong G; Gao LJ; Liu TJ; Cao WJ
    J Cancer Res Clin Oncol; 2015 Sep; 141(9):1553-61. PubMed ID: 25609073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
    Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
    Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly.
    Murakami H; Kohno E; Kohmura Y; Ozawa H; Ito H; Sugihara K; Horiuchi K; Hirano T; Kanayama N
    Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):259-63. PubMed ID: 19747245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
    Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
    Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantages of laserphyrin compared with photofrin in photodynamic therapy for bile duct carcinoma.
    Nonaka T; Nanashima A; Nonaka M; Uehara M; Isomoto H; Nonaka Y; Nagayasu T
    J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):592-600. PubMed ID: 21360081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of drug-light interval on the mode of action of Photofrin photodynamic therapy in a mouse tumor model.
    Li LB; Luo RC
    Lasers Med Sci; 2009 Jul; 24(4):597-603. PubMed ID: 18936869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants of photodynamic therapy for lung cancers.
    Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
    Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porfimer Sodium Versus PS785 for Photodynamic Therapy (PDT) of Lung Cancer Xenografts in Mice.
    Nwogu C; Kloc A; Attwood K; Bshara W; Durrani F; Pandey R
    J Surg Res; 2021 Jul; 263():245-250. PubMed ID: 33713956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
    Lilge L; Wilson BC
    J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Photodynamic therapy for gastric cancer].
    Mimura S; Narahara H; Uehara H; Otani T; Okuda S
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):41-6. PubMed ID: 8546468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced susceptibility of mouse squamous cell carcinoma to photodynamic therapy combined with low-dose administration of cisplatin.
    Uehara M; Inokuchi T; Ikeda H
    J Oral Maxillofac Surg; 2006 Mar; 64(3):390-6. PubMed ID: 16487799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy for experimental tumors using ATX-S10(Na), a hydrophilic chlorin photosensitizer, and diode laser.
    Mori M; Sakata I; Hirano T; Obana A; Nakajima S; Hikida M; Kumagai T
    Jpn J Cancer Res; 2000 Jul; 91(7):753-9. PubMed ID: 10920284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.